Literature DB >> 16258809

Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma.

Kazuhiro Kondo1, Kazuo Chijiiwa, Ichiro Makino, Masahiro Kai, Naoki Maehara, Jiro Ohuchida, Seiji Naganuma.   

Abstract

BACKGROUND/
PURPOSE: Although most patients who receive hepatectomy for a solitary hepatocellular carcinoma (HCC) have a relatively fair result, some have a poor prognosis. The aim of this study was to evaluate the risk factors for early death after hepatectomy in patients with a solitary HCC.
METHODS: Eligible patients (n=110) who had undergone hepatectomy for solitary HCC between 1990 and 2002 and were able to be followed up for more than 2 years after the hepatectomy were divided into two groups, those who died of cancer recurrence within 2 years (early-death group; n=18) and those who survived for more than 2 years after the surgery (survival group; n=92). Risk factors for early death after liver resection were evaluated by univariate and multivariate analyses.
RESULTS: The gross tumor classification, tumor diameter, macroscopic portal vein invasion, microscopic growth pattern, microscopic vascular invasion (MVI), and the width of the surgical margin were significant (P<0.05) factors by univariate analysis. Multivariate analysis showed that the presence of MVI was an independent and significant risk factor for early death of recurrence.
CONCLUSIONS: Among patients with solitary HCC, the presence of MVI indicates a poor prognosis. These patients need adjuvant chemotherapy in the early period after hepatectomy.

Entities:  

Mesh:

Year:  2005        PMID: 16258809     DOI: 10.1007/s00534-005-1009-9

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  14 in total

1.  Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion.

Authors:  Naoki Ikenaga; Kazuo Chijiiwa; Kazuhiro Otani; Jiro Ohuchida; Shuichiro Uchiyama; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2008-11-15       Impact factor: 3.452

2.  Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda; Seiji Okuda; Katsuhiko Otobe; Kenichi Takahashi
Journal:  Eur Radiol       Date:  2014-06-22       Impact factor: 5.315

3.  Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Seiji Okuda; Sadanobu Ogawa; Takumi Igura; Yasuharu Imai
Journal:  J Gastroenterol       Date:  2014-02-22       Impact factor: 7.527

4.  Expression of hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma and postoperative outcomes.

Authors:  Mayumi Funagayama; Kazuhiro Kondo; Kazuo Chijiiwa; Hiroaki Kataoka
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

5.  Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.

Authors:  Satoru Imura; Hiroki Teraoku; Masato Yoshikawa; Daichi Ishikawa; Shinichiro Yamada; Yu Saito; Shuichi Iwahashi; Tetsuya Ikemoto; Yuji Morine; Mitsuo Shimada
Journal:  Int J Clin Oncol       Date:  2017-09-05       Impact factor: 3.402

6.  Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.

Authors:  Han Zhang; Shou-Xin Yuan; Shu-Yang Dai; Jin-Min Zhang; Xing Huang; Chong-De Lu; Jun-Hua Lu; Fu-Quan Wu; Wan Yee Lau; Meng-Chao Wu; Tian Yang; Feng Shen
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

7.  Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Authors:  Le-Le Lu; Jing Sun; Jie-Juan Lai; Yan Jiang; Lian-Hua Bai; Lei-Da Zhang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

8.  Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma.

Authors:  Karim M Eltawil; Mark Kidd; Francesco Giovinazzo; Ahmed H Helmy; Ronald R Salem
Journal:  World J Surg Oncol       Date:  2010-05-24       Impact factor: 2.754

9.  Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.

Authors:  Toshiya Kamiyama; Kazuaki Nakanishi; Hideki Yokoo; Hirofumi Kamachi; Munenori Tahara; Tatsuhiko Kakisaka; Yosuke Tsuruga; Satoru Todo; Akinobu Taketomi
Journal:  World J Surg Oncol       Date:  2012-06-14       Impact factor: 2.754

10.  Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.

Authors:  Jian-Lin Chen; Xiang-Ming Lao; Xiao-Jun Lin; Li Xu; Bo-Kang Cui; Jun Wang; Guo-He Lin; Ze-Yu Shuang; Yi-Ze Mao; Xin Huang; Jing-Ping Yun; Jie-Tian Jin; Sheng-Ping Li
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.